Thaum ntsib tus kab mob HIV, nws yog ib qho tseem ceeb rau nrhiav kev kho mob uas muaj txiaj ntsig zoo rau tus kab mob no thaum txo cov kev mob tshwm sim hauv metabolic. Nws yog ib yam tshuaj tiv thaiv kab mob uas ua haujlwm los ntawm cov txheej txheem tshwj xeeb. Kab lus no yuav piav qhia txog cov txheej txheem ntawm kev ua ntawm Atazanavir, nws cov kev siv tshuaj kho mob, thiab nws lub luag haujlwm tseem ceeb hauv kev tswj hwm tus kab mob HIV.
Dab tsi yog Atazanavir
Atazanavir APIyog ib qho tshuaj tiv thaiv kab mob uas feem ntau siv los kho tus kab mob HIV. Nws belongs rau cov chav kawm ntawm protease inhibitors, uas ua haujlwm los ntawm inhibiting lub protease enzyme xav tau rau HIV replication, yog li txo cov kab mob hauv lub cev. Nws inhibits kev ua ntawm protease, ib qho tseem ceeb enzyme nyob rau hauv maturation ntawm kis kab mob. Los ntawm kev thaiv cov txheej txheem no, cov tshuaj pab txo qis cov kab mob sib kis thiab yog li tswj tau tus kab mob. Rau kev pom zoo, nws yuav tsum tau noj nrog zaub mov. Qhov no txhim kho nws cov txiaj ntsig thiab pab tswj kom muaj cov tshuaj txaus hauv lub cev.
Cov tshuaj no feem ntau yog siv los ua ib feem ntawm kev kho mob sib xyaw ua ke rau HIV, uas yog qhov tseem ceeb rau kev tiv thaiv kev txhim kho ntawm kev tiv thaiv thiab txhim kho cov txiaj ntsig kev kho mob. Nws haum rau cov neeg laus thiab cov menyuam yaus uas muaj tus kab mob HIV-1. Cov kev tshawb fawb tau pom tias nws muaj txiaj ntsig zoo tiv thaiv tus kab mob thiab txhim kho kev tiv thaiv kab mob. Qee hom kab mob HIV tuaj yeem tiv thaiv Atazanavir; Yog li ntawd, kev ntsuam xyuas kuj feem ntau pom zoo ua ntej kev kho mob raws li ib feem ntawm txoj kev kho mob zoo. Vim nws cov txiaj ntsig zoo thiab cov txiaj ntsig zoo ntawm qhov profile, nws tau dhau los ua qhov tseem ceeb hauv kev kho mob HIV. Cov neeg mob thiab lawv cov kws kho mob yuav tsum ua hauj lwm ua ke los tsim ib txoj kev npaj kho mob, suav nrog kev saib xyuas tsis tu ncua thiab ua raws li cov kev cai nruj heev. Yog tias koj txaus siab rau Atazanavir, thov hu rau Xi'an Sonwu.
Dab tsi yog Atazanavir siv rau
Cov khoom no yog ib qho tseem ceeb tshuaj tiv thaiv kab mob feem ntau siv los kho tus kab mob human immunodeficiency virus (HIV). Nws txhim kho qhov kev cia siab ntawm cov neeg mob HIV los ntawm kev kho ua ke. Kev siv nws yuav tsum muaj kev qhia txog kev kho mob kom sib npaug ntawm kev ua tau zoo, kev nyab xeeb, thiab kev xav tau ntawm tus kheej. Yog tias koj muaj kev txhawj xeeb txog kev noj qab haus huv tshwj xeeb, thov mus ntsib kws kho mob rau cov lus qhia tus kheej. Hauv qab no yog cov ncauj lus kom ntxaws txog nws cov kev siv.
Lub hom phiaj tseem ceeb ntawm kev siv thiab kev kho mob yog kho tus kab mob HIV-1, haum rau cov neeg laus thiab menyuam yaus (feem ntau yog 6 xyoo thiab laus dua). Raws li ib feem tseem ceeb ntawm kev kho tshuaj tiv thaiv kab mob (ART), nws pab tswj kev kis tus kab mob los ntawm kev txo cov kab mob hauv cov ntshav (piv txwv li, HIV RNA qib). Qhov no yuav pab tau:
1. Ua kom lub cev tiv thaiv kab mob qeeb
Tus kab mob HIV tawm tsam CD4+ T hlwb, ua rau lub cev tsis muaj zog. Atazanavir, los ntawm inhibiting viral replication, pab tswj los yog nce CD4 cell suav, yog li ncua kev loj hlob ntawm AIDS.
2. Txhim kho lub neej zoo
Kev tswj hwm tus kab mob HIV zoo tuaj yeem txo qhov kev pheej hmoo ntawm kev kis tus kab mob kis tau zoo thiab cov kab mob malignancies, ua rau cov neeg mob ua neej nyob ntev thiab noj qab haus huv.
3. Tiv thaiv kev sib kis
Thaum cov kab mob kis tau mus rau qib tsis paub, Atazanavir, ua ke nrog lwm cov tshuaj ART, kuj tuaj yeem txo qhov kev pheej hmoo ntawm kev kis tus kabmob HIV los ntawm kev sib deev lossis niam- mus rau- kis tus menyuam.
Qhov tseem ceeb ntawm kev sib xyaw ua ke
Cov tshuaj no tsis tshua siv ib leeg, tab sis yog ib feem ntawm kev sib xyaw ART. Qhov no yog vim:
1. Txhim khu kev ua tau zoo thiab tiv thaiv kev tiv thaiv
HIV muaj feem cuam tshuam rau kev hloov pauv thiab txhim kho kev tiv thaiv. Combining drugs with multiple mechanisms of action (such as this drug with nucleoside reverse transcriptase inhibitors (NRTIs) or integrase inhibitors) can work synergistically to suppress the virus and reduce the risk of resistance more effectively.
2. Pharmacokinetic li
Cov tshuaj no, thaum ua ke nrog qis - koob tshuaj CYP3A4 enzyme inhibitor, tuaj yeem ua rau nws cov metabolism qeeb, ua kom nws cov ntshav siab thiab ib nrab - lub neej, thiab txhim kho kev ua raws li tus neeg mob.
3. Cov txheej txheem kev kho mob
Raws li cov lus qhia thoob ntiaj teb (xws li cov los ntawm WHO thiab US DHHS), cov tshuaj no feem ntau yog siv rau thawj zaug - lossis thib ob - kab kev kho mob, tshwj xeeb tshaj yog rau kev kho mob - cov neeg mob tsis zoo lossis cov tsis kam rau lwm cov tshuaj.
Dab tsi yog Lub Mechanism Ntawm Kev Ua Ntawm Atazanavir
Atazanavir yog tus kab mob HIV -1 protease inhibitor (PI). Nws cov txheej txheem ntawm kev ua tau zoo-txhais tau zoo, feem ntau ua los ntawm kev thaiv cov kab mob HIV protease, ib qho enzyme tseem ceeb rau kev loj hlob thiab kis tus kab mob. Lub mechanism yog raws li nram no:
1. Inhibition ntawm HIV-1 protease:
Atazanavir xaiv khi rau thiab inhibits HIV-1 protease, ib qho enzyme tseem ceeb rau kev rov ua dua tus kab mob. HIV protease feem ntau cleaves viral gag thiab gag-pol polyprotein precursors rau hauv lawv cov khoom ua haujlwm (xws li, capsid protein, thim rov qab transcriptase, integrase). Cov khoom no yog tsim nyog rau kev sib sau ua ke ntawm cov laus, cov kab mob sib kis.
2. Los ntawm kev thaiv cov kev ua ntawm cov protease, Atazanavir tiv thaiv cov txheej txheem maturation ntawm tus kab mob. Yog li ntawd, cov kab mob tshiab uas tsim tawm tseem tsis paub qab hau, ua haujlwm tsis zoo, thiab tsis tuaj yeem kis cov hlwb tshiab.
3. Thaum nws yog siv los ua ib feem ntawm kev sib xyaw tshuaj tiv thaiv kab mob (ART), kev tsim cov kab mob uas tsis yog- kis kab mob ua rau txo qis ntawm tag nrho cov kab mob.
Cov yam ntxwv tshwj xeeb pharmacological:
Piv nrog rau lwm yam protease inhibitors:
Nws muaj kev cuam tshuam qis rau cov qib lipid thiab feem ntau ua rau muaj kev cuam tshuam ntawm metabolic tsawg.
Inhibition ntawm UGT1A1 enzyme yuav ua rau benign indirect hyperbilirubinemia.
Nws feem ntau yog siv ua ke nrog lwm cov tshuaj kom nce ntshav plasma concentration.
Yog tias koj xav nug txog tus nqi ntawm Atazanavir AP! los yog thov lwm cov ntaub ntawv khoom, thov hu rau Xi'an Son ncaj qha.
Email:sales@sonwu.com
Siv: https://hivevidence.org/optimizing-art-adherence-update-for-hiv-treatment-thiab-prevention/